X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 560 | 563 | 0 | 0 | 0 |
| Cost of Goods | 227 | 268 | N/A | N/A | 0 |
| Gross Profit | 333 | 295 | N/A | N/A | N/A |
| Operating Expenses | 35,060 | -70,540 | 37,289 | 25,199 | 27,214 |
| Operating Income | -34,500 | 71,103 | -37,289 | -25,199 | -27,214 |
| Interest Expense | 2,414 | 2,176 | 1,874 | 1,886 | 1,634 |
| Other Income | 233 | 21,924 | -12,584 | 7,988 | 26,569 |
| Pre-tax Income | -36,681 | 90,851 | -51,747 | -19,097 | -2,279 |
| Income Tax | 15 | 18 | 19 | 33 | 26 |
| Net Income Continuous | -36,696 | 90,833 | -51,766 | -19,130 | -2,305 |
| Net Income | $-36,696 | $90,833 | $-51,766 | $-19,130 | $-2,305 |
| EPS Basic Total Ops | -5.48 | 13.59 | -7.77 | -2.06 | -0.30 |
| EPS Basic Continuous Ops | -5.48 | 13.60 | -7.77 | -1.86 | -0.35 |
| EPS Diluted Total Ops | -5.48 | 13.57 | -7.77 | -2.06 | -0.30 |
| EPS Diluted Continuous Ops | -5.48 | 13.57 | -7.77 | -1.86 | -0.35 |
| EPS Diluted Before Non-Recurring Items | -5.41 | -2.10 | -7.81 | N/A | N/A |
| EBITDA(a) | $-34,233 | $71,297 | $-37,227 | $-25,137 | $-27,110 |